2 results
Approved WMOCompleted
Evaluation of the effects of octreotide LAR in head-and-neck paraganglioma on:1. tumor volume 2. catecholamine produktion 3. clinical and biochemical parameters
Approved WMORecruiting
Primary Objectives- Determine the MTD of pixantrone, rituximab (only in CD20 positive tumors), etoposide, and bendamustine in *fit' patients with rel aNHL of B- or T-cell phenotype.- Evaluate the ORR and PFS using the combination of pixantrone…